Edition:
United States

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

892.05INR
5:13am EST
Change (% chg)

Rs20.95 (+2.41%)
Prev Close
Rs871.10
Open
Rs877.00
Day's High
Rs895.00
Day's Low
Rs868.55
Volume
335,232
Avg. Vol
583,510
52-wk High
Rs994.00
52-wk Low
Rs671.10

Latest Key Developments (Source: Significant Developments)

Glenmark Pharmaceuticals Sept qtr consol profit up about 11 pct
Thursday, 27 Oct 2016 06:30am EDT 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals - sept-quarter consol net profit 2.19 billion rupees . Glenmark Pharmaceuticals - sept-quarter consol net sales 21.73 billion rupees . Glenmark Pharmaceuticals consensus forecast for sept quarter consol net profit was 2.6 billion rupees . Glenmark Pharmaceuticals - consol net profit in sept quarter last year was 1.98 billion rupees as per IFRS; consol net sales was 18.79 billion rupees .Glenmark Pharmaceuticals-in the next quarter, Glenmark intends to file seven anda applications with the U.S FDA.  Full Article

Glenmark Pharmaceuticals gets exclusive commercial marketing rights for generic Abraxane
Monday, 19 Sep 2016 05:45am EDT 

Glenmark Pharmaceuticals Ltd : Announces strategic development and global licensing agreement with Particle Sciences, Inc., a lubrizol company, for generic Abraxane . Development initiated for US market with anda expected to be filed in FY 2019; subsequently product to be filed in other key markets . Particle sciences to get milestone payments on various stages of product's development from Glenmark, including royalties on sales . Glenmark obtains global exclusive commercial marketing and distribution rights for generic Abraxane .  Full Article

Glenmark Pharma gets USFDA nod for generic version of Solaraze
Tuesday, 13 Sep 2016 10:53pm EDT 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals receives ANDA approval for diclofenac sodium gel, 3% .  Full Article

Glenmark Pharma gets ANDA approval for lidocaine ointment
Sunday, 11 Sep 2016 11:32pm EDT 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals receives ANDA approval for lidocaine ointment USP, 5% .  Full Article

Glenmark Pharma June-qtr consol profit up 24 pct
Friday, 12 Aug 2016 01:49am EDT 

Glenmark Pharmaceuticals Ltd : June-quarter consol net profit 2.27 billion rupees . Says June-quarter consol revenue 19.43 billion rupees . Consensus forecast for June-quarter net profit was 2.18 billion rupees . U.S. business continues to perform well . U.S. business grew by 24.44% to 6.98 billion rupees in June-quarter . Consol net profit in June-quarter last year was 1.83 billion rupees as per Ind-AS; consol net sales was 16.26 billion rupees .  Full Article

Glenmark Pharma gets FDA nod for generic version of Kenalog cream
Sunday, 7 Aug 2016 11:11pm EDT 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals receives ANDA approval for triamcinolone acetonide cream USP, 0.1% .  Full Article

Glenmark Pharma gets ANDA approval for potassium chloride tablets
Tuesday, 26 Jul 2016 10:56pm EDT 

Glenmark Pharmaceuticals Ltd : Receives ANDA approval for potassium chloride extended-release tablets USP, 10 MEQ (750 mg) and 20 MEQ (1500 mg) .  Full Article

Glenmark Pharma Closes $200 mln bond issue
Tuesday, 26 Jul 2016 12:07am EDT 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals announces the successful closure of its USD 200 mln Reg S USD Bond . The bonds were oversubscribed 8 times . Proceeds will be used for investment in units abroad and repay debt .  Full Article

Glenmark Pharma gets FDA nod for generic triamcinolone acetonide ointment
Sunday, 24 Jul 2016 11:04pm EDT 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals receives ANDA approval for triamcinolone acetonide ointment USP, 0.5% .  Full Article

Glenmark Pharma to raise $200 mln via issue of USD bonds
Sunday, 17 Jul 2016 10:55pm EDT 

Glenmark Pharmaceuticals Ltd : Glenmark pharmaceuticals ltd.- plans to issue a usd denominated international bond for repaying its existing debt . Glenmark pharmaceuticals ltd.- the net proceeds will be used for repaying the existing debt. . Glenmark pharmaceuticals ltd.- planning to raise around USD 200 million by issuing usd denominated non-convertible unsecured bonds . Glenmark pharmaceuticals ltd.- bonds are planned to be listed on the Singapore stock exchange ` .  Full Article

BRIEF-Glenmark Pharmaceuticals Sept qtr consol profit up about 11 pct

* Glenmark Pharmaceuticals - sept-quarter consol net profit 2.19 billion rupees